Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
about
Celecoxib for rheumatoid arthritisDown-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activityBiologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drugAssociation between anti-TNF therapy for rheumatoid arthritis and hypertension: a meta-analysis of randomized controlled trials.Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.Celecoxib for rheumatoid arthritis
P2860
Q24186209-E2F85D68-889C-4FEE-A91C-3D580D5F255AQ24193435-11B08997-F0FD-4C09-B4D5-5735F5F813DBQ30235341-971970B8-9CB5-492D-9DA9-EF3B47D6D10CQ35336802-37C75319-396B-49F3-B1A5-4AB58980CF50Q35599025-1FF1404F-2E2C-477D-8B18-151C3BEFDB07Q36195284-51D6962D-224B-44DD-9CA5-48996DE05A26Q47836056-34C60AC8-6C0B-469C-8749-FF8E968C4194Q55025616-7D4EE265-456D-4194-A528-01FA8E7C876CQ57318857-F5F63E32-E930-4365-921C-AE98B34F92D8
P2860
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@ast
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en-gb
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@nl
type
label
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@ast
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en-gb
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@nl
prefLabel
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@ast
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en-gb
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@nl
P2093
P2860
P31
P1476
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
@en
P2093
Francis JB Kynaston-Pearson
Juan B Cabello
Paloma Vela Casasempere
Paresh Jobanputra
Sylvia Bort-Marti
Vicente Ruiz Garcia
P2860
P304
P356
10.1002/14651858.CD007649.PUB3
P407
P50
P577
2014-09-18T00:00:00Z